Phentolamine

Oraverse

0.4 MG / 1.7 ML SolutionCanadaMarketedAuthorised 17 Sept 2014

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Phentolamine

Oraverse

0.4 MG / 1.7 ML SolutionCanadaMarketedAuthorised 17 Sept 2014

Open in the registerAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Regitine AmpSaudi Arabia · Novartis

Phentolamine MesylateUnited States · 5MG/VIAL · injectable · Hikma

Documents

The official texts, at the regulator.

Register entryHealth Canada

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Health Canada, Canada

Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada · Added 13 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Phentolamine
Strength: 0.4 MG / 1.7 ML
Dosage form: Solution
Route: Submucosal
Register: Canada (Health Canada)
Status: Marketed
Authorised: 17 Sept 2014
Registration: DIN 02421666
Marketing authorisation holder: Septodont
ATC code: V03AB36
Group: Various
Supply: PRESCRIPTION

Rogitine 5MG/VialPhentolamine · 5 MG / AMP · Powder For SolutionCanadaCancelled